Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)

1d ago, source:

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Terns Pharmaceuticals (TERN – Research Report), Abbott Labs ...

Terns Pharmaceuticals, Inc. (TERN)

4d ago, source: Yahoo Finance

FOSTER CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage ...

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

13d ago, source:

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...

This small-cap stock is expected to take off — if its weight-loss pill trial succeeds

on MSN ago, source:

The stock of small-cap Terns Pharmaceuticals Inc. rose 6% on Thursday, amid bullish analyst comment on the company’s pipeline ...

Terns Pharmaceuticals Welcomes Amy Burroughs as CEO

2mon ago, source: TipRanks on MSN

Terns Pharmaceuticals, Inc. has appointed Amy Burroughs as their new CEO and Director, effective February 7, 2024. Burroughs ...

Terns Pharmaceuticals Inc Ordinary Shares

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

1mon ago, source: Business Insider

FOSTER CITY, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage ...

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

1mon ago, source: Stockhouse

March 14, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company ...

Terns Pharmaceuticals Inc (TERN)

1mon ago, source: Investing

After-Hours Stock Movers: Mind Medicine Inc. (Nasdaq: MNMD) 33% LOWER; today announced that it intends to offer and sell, subject to market conditions, common shares with ...